Analysts expect South State Corporation (NASDAQ:SSB) to report $1.47 EPS on July, 20.They anticipate $0.29 EPS change or 24.58% from last quarter’s $1.18 EPS. SSB’s profit would be $53.89M giving it 15.18 P/E if the $1.47 EPS is correct. After having $1.39 EPS previously, South State Corporation’s analysts see 5.76% EPS growth. The stock decreased 0.11% or $0.1 during the last trading session, reaching $89.25. About 293,306 shares traded or 132.17% up from the average. South State Corporation (NASDAQ:SSB) has risen 7.27% since June 15, 2017 and is uptrending. It has underperformed by 5.30% the S&P500. Some Historical SSB News: ; 24/04/2018 – SOUTH STATE CORP – QTRLY NET INTREST INCOME $ 128.97 MLN VS $ 97.4 MLN; 07/03/2018 – SOUTH STATE CORP. FILES MIXED SECURITIES SHELF; 20/04/2018 – DJ South State Corporation, Inst Holders, 1Q 2018 (SSB); 24/04/2018 – South State 1Q Cash and Cash Equivalents Increased by $266.9M; 24/04/2018 – SOUTH STATE BOOSTS QTR DIV TO 34C/SHR FROM 33C, EST. 34C; 24/04/2018 – SOUTH STATE CORP – EFFECTIVE JULY 1, 2018, CAP ON INTERCHANGE FEES UNDER DURBIN AMENDMENT WILL BE IN PLACE FOR COMPANY; 24/04/2018 – SOUTH STATE 1Q ADJ EPS $1.39, EST. $1.42; 24/04/2018 – SOUTH STATE 1Q ADJ EPS $1.39; 25/04/2018 – SOUTH STATE CORP SSB.O : KBW CUTS TO MARKET PERFORM FROM OUTPERFORM; 23/04/2018 – South State Closes Above 200-Day Moving Average: Technicals
Conmed Corp (CNMD) investors sentiment decreased to 1.27 in 2018 Q1. It’s down -0.03, from 1.3 in 2017Q4. The ratio dived, as 79 investment managers increased and started new equity positions, while 62 reduced and sold holdings in Conmed Corp. The investment managers in our database now have: 26.34 million shares, down from 26.91 million shares in 2017Q4. Also, the number of investment managers holding Conmed Corp in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 13 Reduced: 49 Increased: 51 New Position: 28.
Analysts await CONMED Corporation (NASDAQ:CNMD) to report earnings on July, 25. They expect $0.45 earnings per share, up 9.76% or $0.04 from last year’s $0.41 per share. CNMD’s profit will be $12.62 million for 41.04 P/E if the $0.45 EPS becomes a reality. After $0.53 actual earnings per share reported by CONMED Corporation for the previous quarter, Wall Street now forecasts -15.09% negative EPS growth.
Since January 1, 0001, it had 1 buy, and 10 insider sales for $4.11 million activity.
Krensavage Asset Management Llc holds 2.52% of its portfolio in CONMED Corporation for 163,924 shares. Investment Counselors Of Maryland Llc owns 286,423 shares or 0.93% of their US portfolio. Moreover, Champlain Investment Partners Llc has 0.91% invested in the company for 1.32 million shares. The Massachusetts-based Granahan Investment Management Inc Ma has invested 0.9% in the stock. Cramer Rosenthal Mcglynn Llc, a New York-based fund reported 796,494 shares.
CONMED Corporation, a medical technology company, develops, makes, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $2.07 billion. The firm offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues. It has a 29.69 P/E ratio. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, suction irrigation devices, graspers, scissors, and dissectors used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures.
The stock increased 1.50% or $1.09 during the last trading session, reaching $73.87. About 109,251 shares traded. CONMED Corporation (CNMD) has risen 35.27% since June 15, 2017 and is uptrending. It has outperformed by 22.70% the S&P500. Some Historical CNMD News: ; 25/04/2018 – CONMED CORP – POSITIVE IMPACT TO 2018 SALES FROM FOREIGN EXCHANGE IS ANTICIPATED TO BE BETWEEN 100 AND 150 BASIS POINTS; 24/05/2018 – CONMED Corporation Announces Quarterly Cash Dividend; 25/04/2018 – Conmed Closes Above 50-Day Moving Average: Technicals; 25/04/2018 – CONMED CORP – RAISES FULL-YEAR 2018 FINANCIAL GUIDANCE; 20/04/2018 – Conmed Presenting at Bank of America Conference May 15; 24/03/2018 – FDA: ConMed Corporation- MINI INFANT < 3KG, RADIOTRANSLUCENT ELECTRODE, Physio-Control® Quik-Combo" Connector, REF/Catalog; 14/05/2018 - Conmed Presenting at Bank of America Conference Tomorrow; 25/04/2018 - CONMED 1Q ADJ EPS 53C, EST. 44C; 25/04/2018 - CONMED Raises FY18 View To Adj EPS $2.15-Adj EPS $2.20; 24/03/2018 - FDA: ConMed Corporation- MINI INFANT < 3KG, RADIOTRANSLUCENT ELECTRODE, ZOLL® Connector, REF/Catalog Number 2602Z Indicat
Another recent and important South State Corporation (NASDAQ:SSB) news was published by Globenewswire.com which published an article titled: “Recent Analysis Shows ABM Industries, Waddell & Reed Financial, South State, Vera Bradley, Healthcare Trust of …” on May 23, 2018.
South State Corporation operates as the bank holding firm for South State Bank that provides a range of retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans. The company has market cap of $3.27 billion. It accepts demand deposits, savings deposits, interest-bearing demand deposits, certificates of deposit, and other time deposits; and offers lending and credit card, ATM processing, and wealth management and trust services. It has a 30.46 P/E ratio. The firm also provides investment advisory and broker dealer services.
Among 9 analysts covering South State Corp (NASDAQ:SSB), 2 have Buy rating, 0 Sell and 7 Hold. Therefore 22% are positive. South State Corp had 38 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of South State Corporation (NASDAQ:SSB) earned “Hold” rating by Brean Capital on Monday, January 29. The rating was maintained by Brean Capital with “Hold” on Monday, April 23. The firm has “Neutral” rating given on Monday, September 21 by Piper Jaffray. The rating was maintained by Brean Capital with “Hold” on Tuesday, January 23. The stock of South State Corporation (NASDAQ:SSB) earned “Hold” rating by Brean Capital on Monday, February 5. As per Monday, October 30, the company rating was maintained by Brean Capital. The stock of South State Corporation (NASDAQ:SSB) earned “Hold” rating by Keefe Bruyette & Woods on Wednesday, April 25. The stock of South State Corporation (NASDAQ:SSB) has “Outperform” rating given on Monday, June 20 by Wood. The firm has “Hold” rating given on Wednesday, March 28 by Sandler O’Neill. The firm has “Buy” rating by SunTrust given on Tuesday, April 24.